Healthcare Shift: How the Biosimilars Market Analysis Predicts a New Era of Affordable Biologics
The global pharmaceutical landscape is witnessing a monumental shift as the focus moves from traditional small-molecule drugs to complex biological therapies. Biologics have revolutionized the treatment of chronic diseases such as cancer, rheumatoid arthritis, and diabetes. However, the high cost of these innovator drugs has often limited patient access. This has paved the way for the rise of...
0 Commentarii 0 Distribuiri 132 Views 0 previzualizare